| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Lorenzo Leggio | |
| Robert M Swift | |||
| George A Kenna | |||
| Steven Edwards | |||
| P433 | issue | 14 | |
| P921 | main subject | pharmacotherapy | Q701216 |
| alcohol dependence | Q4713263 | ||
| P304 | page(s) | 1323-1332 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Current Pharmaceutical Design | Q5195068 |
| P1476 | title | Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review | |
| P478 | volume | 17 |
| Q42542870 | A Call to Action: Alcohol Interventions in HIV-Infected Patients |
| Q34212648 | A pilot examination of the genome-wide DNA methylation signatures of subjects entering and exiting short-term alcohol dependence treatment programs |
| Q35876092 | A single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm |
| Q48099438 | Activation of amylin receptors attenuates alcohol-mediated behaviours in rodents |
| Q39090733 | Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks? |
| Q91312520 | An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder |
| Q36807410 | Caenorhabditis elegans as a Model to Study the Molecular and Genetic Mechanisms of Drug Addiction |
| Q38185313 | Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date |
| Q33944003 | Different contributions of dopamine D1 and D2 receptor activity to alcohol potentiation of brain stimulation reward in C57BL/6J and DBA/2J mice |
| Q52301706 | Differential effects of baclofen and oxytocin on the increased ethanol consumption following chronic psychosocial stress in mice. |
| Q24198009 | Disulfiram for alcohol use disorder |
| Q94398620 | Disulfiram for alcohol use disorder |
| Q46846272 | Efficacy of D-penicillamine, a sequestering acetaldehyde agent, in the prevention of alcohol relapse-like drinking in rats. |
| Q30234425 | Emerging concepts in alcoholic hepatitis |
| Q33591091 | Genetic influences on response to alcohol and response to pharmacotherapies for alcoholism |
| Q47851680 | Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin |
| Q41883032 | Histamine h3 receptor: a novel therapeutic target in alcohol dependence? |
| Q52318135 | In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5. |
| Q34250821 | Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation |
| Q41270245 | Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving |
| Q37165425 | Management of alcohol dependence in patients with liver disease. |
| Q24234860 | Nicotine receptor partial agonists for alcohol dependence |
| Q26472086 | Nicotine receptor partial agonists for alcohol dependence |
| Q91741196 | Noninvasive 40-Hz Light Flicker Rescues Circadian Behavior and Abnormal Lipid Metabolism Induced by Acute Ethanol Exposure via Improving SIRT1 and the Circadian Clock in the Liver-Brain Axis |
| Q34223054 | Pharmacotherapy for alcoholic patients with alcoholic liver disease |
| Q46518690 | Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease |
| Q36440595 | Recruitment techniques for alcohol pharmacotherapy clinical trials: A cost-benefit analysis |
| Q28109507 | Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy |
| Q34765276 | Serotonin-2C receptor agonists decrease potassium-stimulated GABA release in the nucleus accumbens |
| Q30373948 | Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: Data from a national sample of treatment organizations |
| Q30453661 | The CRF system and social behavior: a review |
| Q37410052 | The mean and the individual: integrating variable-centered and person-centered analyses of cognitive recovery in patients with substance use disorders |
| Q88574413 | The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study |
| Q26992207 | The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans |
| Q39041281 | Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease |
| Q37276159 | Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials |
Search more.